Latest Period
n/a
Security Snapshot
Protara Therapeutics, Inc. - Common Stock, $0.001 par value per share (the "Shares") Institutional Ownership
CUSIP: 74365U107
13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, $0.001 par value per share (the "Shares")
- Shares outstanding
- 34,632,638
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- 74365U107 - Protara Therapeutics, Inc. - Common Stock, $0.001 par value per share (the "Shares") is tracked under CUSIP 74365U107.
- Latest finished 13F holder period is not available.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 4 between Q3 2024 and Q4 2025.
- Reported value moved from $48,678 to $22,018,919.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
74365U107
Latest holder period
n/a
13F holders
13D/G owners
1
CIK / CUSIP context first
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 74365U107:
Significant Owners of Protara Therapeutics, Inc. - Common Stock, $0.001 par value per share (the "Shares") based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 4.7% | 1,627,734 | Kenneth Griffin | 31 Dec 2024 |